Further processing options
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment
Saved in:
Journal Title: | Journal of Thrombosis and Haemostasis |
---|---|
Authors and Corporations: | , |
In: | Journal of Thrombosis and Haemostasis, 15, 2017, 12, p. 2466-2467 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |